Medicinal Products

AMOROLFINE EG LABO BOARD 5%

Generic drug from Loceryl
Therapeutic Class: Diagnostic Products or Other Therapeutic Products
active ingredients: Amorolfine
laboratory: EG Labo

Medicated nail polish
bottle of 250 ml
All forms

Indication

Treatment of distal and moderate lateral subungan onychomycosis, caused by dermatophytes, yeasts or molds, affecting no more than two nails in adults.

Dosage AMOROLFINE EG LABO CONSEIL 5% medicated nail varnish 250 ml bottle

Treatment of distal and moderate lateral subungan onychomycosis, caused by dermatophytes, yeasts or molds, affecting no more than two nails in adults.

Against indications

Hypersensitivity to the active substance or to any of the excipients listed under Composition .

Adverse effects Amorolfine Eg Labo Tip

The reactions to the product are rare.

Skin and subcutaneous tissues

Since the marketing have been reported:

 · Ungular abnormalities (eg, uneven dyschromias, brittle nail, fragile nail). However, these reactions can be directly related to onychomycosis.

 · Sensations of skin burns and contact dermatitis.

Body Class System

Frà © quence

Inadmissible effects

Skin and subcutaneous tissue disorders

Rare

(³1 / 10, 000, <1/1000)

Nail abnormality, nail staining, brittle nails (onychoclasia), fragile nails (onychorrhexia)

Very rare

(<1 / 10, 000)

Sensation of cutaneous burn

Unlimited frequency (can not be estimated based on available data)

Erythema, pruritus, contact dermatitis, urticaria, phlyctene

Declaration of suspected untoward effects

The declaration of suspected adverse effects after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals disclose any suspected adverse effects via the national reporting system: National Agency for Drug and Health Product Safety (ANSM) and network Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article